PATRICK ASTOURIAN: Open Payments
NPI 1932294279 · LA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,014 in 153 payments from 19 companies in 2025. Trend: 2023 $2,535 · 2024 $2,772 · 2025 $4,014
Food & beverage: $3,907Education: $107
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $979 |
| Amgen Inc. | 32 | $795 |
| Janssen Biotech, Inc. | 16 | $574 |
| Mallinckrodt Hospital Products Inc. | 10 | $378 |
| UCB, Inc. | 15 | $263 |
| ANI Pharmaceuticals, Inc. | 9 | $213 |
| HEARTFLOW, INC. | 1 | $150 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $107 |
| Aurinia Pharma U.S., Inc. | 4 | $91 |
| Lilly USA, LLC | 5 | $82 |
Products named: RINVOQ, TREMFYA, ACTHAR, OTEZLA, SKYRIZI, Bimzelx, KRYSTEXXA, PURIFIED CORTROPHIN GEL.
Industry payments across CA — which companies pay providers there.
